- UroToday Home
- Beyond the Abstracts
- Urologic Oncology
Prostate Cancer
Promise of PET Imaging in Prostate Cancer, Improvement or Waste of Money? With Great Power Comes Great Responsibility - Beyond the Abstract
December 18, 2019
Surgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort - Beyond the Abstract
December 18, 2019
Effect of a Smoking Cessation Program on Sexual Function Recovery Following Robotic Prostatectomy at Kaiser Permanente Southern California - Beyond the Abstract
December 10, 2019
Androgen Deprivation Therapy in Men with Node-positive Prostate Cancer Treated with Post-operative Radiotherapy - Beyond the Abstract
December 3, 2019
The Impact of Diurnal Variation of PSA on Timing of Measurement in Prostate Biopsy - Beyond the Abstract
October 14, 2019
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer - Beyond the Abstract
October 7, 2019
Effect of Prior Local Treatment and Prostate-specific Antigen Kinetics during Androgen-deprivation Therapy - Beyond the Abstract
September 13, 2019
A Multidisciplinary Team Have An Essential Role in Reviewing the Results of Novel Imaging in Patients with Prostate Cancer - Beyond the Abstract
September 13, 2019
Dacomitinib, but Not Lapatinib, Suppressed Progression in Castration-resistant Prostate Cancer Models by Preventing HER2 Increase - Beyond the Abstract
September 13, 2019
Physiological 68Ga-RM2 Uptake in Patients with Biochemically Recurrent Prostate Cancer: An Atlas of Semi-quantitative Measurements - Beyond the Abstract
September 13, 2019
Risk Prediction Tools Available for Germline BRCA1/2 Mutations Underperform in Prostate Cancer Patients - Beyond the Abstract
September 11, 2019
